First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $144.97 | 52-week high | $161.41 |
Prev. close | $142.93 | 52-week low | $130.27 |
Day low | $143.82 | Volume | 18,100 |
Day high | $146.59 | Avg. volume | 28,633 |
50-day MA | $150.74 | Dividend yield | N/A |
200-day MA | $149.31 |
FBT Stock Price Chart Interactive Chart >
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
Issuer | First Trust Portfolios |
Expense Ratio | 0.55% |
Underlying Index | NYSE Arca Biotechnology Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 1.08B |
Net Asset Value (NAV) | $141.69 |
Options? | Yes |
Total Holdings | 32 |
FBT Top Holdings
Symbol | Company | % of Total |
ITCI | Intra-Cellular Therapies Inc. | 3.86% |
AMGN | Amgen Inc. | 3.47% |
BNTX | BioNTech SE (ADR) | 3.47% |
VRTX | Vertex Pharmaceuticals Incorporated | 3.44% |
UTHR | United Therapeutics Corporation | 3.43% |
EXEL | Exelixis Inc. | 3.42% |
HALO | Halozyme Therapeutics Inc. | 3.42% |
MRNA | Moderna Inc. | 3.39% |
REGN | Regeneron Pharmaceuticals Inc. | 3.39% |
ACAD | ACADIA Pharmaceuticals Inc. | 3.38% |
FBT Price Returns
1-mo | -5.54% |
3-mo | -4.13% |
6-mo | 9.41% |
1-year | -5.32% |
3-year | -10.74% |
5-year | 4.93% |
YTD | -8.28% |
2023 | 2.55% |
2022 | -4.83% |
2021 | -2.26% |
2020 | 12.96% |
2019 | 19.74% |